Detalles de la búsqueda
1.
The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial.
Brain Behav Immun
; 99: 147-156, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34624483
2.
Machine learning based prediction and the influence of complement - Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trial.
Brain Behav Immun
; 103: 50-60, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35341915
3.
The association between migrant status and transition in an ultra-high risk for psychosis population.
Soc Psychiatry Psychiatr Epidemiol
; 56(6): 943-952, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33399885
4.
Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis.
Psychother Psychosom
; 86(5): 292-299, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28903120
5.
Proteomic Biomarkers for the Prediction of Transition to Psychosis in Individuals at Clinical High Risk: A Multi-cohort Model Development Study.
Schizophr Bull
; 50(3): 579-588, 2024 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38243809
6.
Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adults.
J Affect Disord
; 326: 249-261, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36586617
7.
Effects of omega-3 polyunsaturated fatty acid supplementation on cognitive functioning in youth at ultra-high risk for psychosis: secondary analysis of the NEURAPRO randomised controlled trial.
BJPsych Open
; 8(5): e165, 2022 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36073014
8.
Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosis.
Transl Psychiatry
; 12(1): 454, 2022 10 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36307392
9.
Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis.
Early Interv Psychiatry
; 15(4): 874-881, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32893462
10.
Characterization and prediction of clinical pathways of vulnerability to psychosis through graph signal processing.
Elife
; 102021 09 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34569937
11.
Synaptic processes and immune-related pathways implicated in Tourette syndrome.
Transl Psychiatry
; 11(1): 56, 2021 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33462189
12.
Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial.
Front Psychiatry
; 11: 514, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32595533
13.
The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis.
Biol Psychiatry
; 87(3): 243-252, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31690495
14.
Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis.
Schizophr Res
; 226: 52-60, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31606244
15.
Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people.
Schizophr Res
; 226: 44-51, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31301881
16.
Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial.
Behav Res Ther
; 124: 103527, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31790853
17.
Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial.
Schizophr Res
; 218: 48-54, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32171637
18.
Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial.
Front Psychiatry
; 10: 393, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31244693
19.
Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.
Schizophr Res
; 206: 67-74, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30558978
20.
Interrogating the Genetic Determinants of Tourette's Syndrome and Other Tic Disorders Through Genome-Wide Association Studies.
Am J Psychiatry
; 176(3): 217-227, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30818990